Shield Therapeutics plc’s Debt and Equity Fundraise

Giulia Di Palma Europe Legal Chronicle
Tagged:

Taylor Wessing advised Shield Therapeutics plc on the deal.Shield Therapeutics plc, an AIM-listed commercial stage specialty pharmaceutical company, extended an existing convertible debt facility by $10 million…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Giulia Di Palma

Author: Giulia Di Palma

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here